IMMOMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
IMMOMED
Largest movements
- Tangible fixed assets -€7,078
down €7,078 (-13.2%), from €53,550 to €46,472
of which Land and buildings: -€5,403
- Profit (loss) carried forward -€7,757
down €7,757 (-12.4%), from -€62,362 to -€70,119
- Gross operating margin -€862
down €862, from €218 to -€644
- Other operating charges +€778
up €778 (+29.2%), from €2,665 to €3,444
- Financial income +€601
up €601 (+18.4%), from €3,263 to €3,864
- Depreciation -€544
down €544 (-7.1%), from €7,622 to €7,078
- Financial charges +€14
up €14 (+3.3%), from €440 to €454
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €155,811 | €148,529 | -€7,282 | -4.7% |
| Fixed assets | 21/28 | €53,798 | €46,720 | -€7,078 | -13.2% |
| Tangible fixed assets | 22/27 | €53,550 | €46,472 | -€7,078 | -13.2% |
| Land and buildings | 22 | €50,994 | €45,591 | -€5,403 | -10.6% |
| Other tangible fixed assets | 26 | €2,555 | €881 | -€1,674 | -65.5% |
| Financial fixed assets | 28 | €248 | €248 | = | 0.0% |
| Current assets | 29/58 | €102,013 | €101,809 | -€204 | -0.2% |
| Amounts receivable within one year | 40/41 | €977 | €1,159 | +€181 | +18.6% |
| Other amounts receivable | 41 | €977 | €1,159 | +€181 | +18.6% |
| Current investments | 50/53 | €80,000 | €80,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €20,987 | €20,189 | -€798 | -3.8% |
| Deferred charges and accrued income | 490/1 | €49 | €462 | +€412 | +834.2% |
| Total equity and liabilities | 10/49 | €155,811 | €148,529 | -€7,282 | -4.7% |
| Equity | 10/15 | €140,130 | €132,374 | -€7,757 | -5.5% |
| Contributions | 10/11 | €198,315 | €198,315 | = | 0.0% |
| Contributions outside capital | 11 | €198,315 | €198,315 | = | 0.0% |
| Other | 1109/19 | €198,315 | €198,315 | = | 0.0% |
| Reserves | 13 | €4,178 | €4,178 | = | 0.0% |
| Non-distributable reserves | 130/1 | €4,178 | €4,178 | = | 0.0% |
| Reserves not available under the articles | 1311 | €4,178 | €4,178 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€62,362 | -€70,119 | -€7,757 | -12.4% |
| Amounts payable | 17/49 | €15,680 | €16,155 | +€475 | +3.0% |
| Amounts payable within one year | 42/48 | €15,680 | €16,155 | +€475 | +3.0% |
| Trade debts | 44 | €574 | €1,010 | +€437 | +76.1% |
| Suppliers | 440/4 | €574 | €1,010 | +€437 | +76.1% |
| Other amounts payable | 47/48 | €15,107 | €15,145 | +€38 | +0.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,622 | €7,078 | -€544 | -7.1% |
| Other operating charges | 640/8 | €2,665 | €3,444 | +€778 | +29.2% |
| Gross operating margin | 9900 | €218 | -€644 | -€862 | |
| Operating profit (loss) | 9901 | -€10,069 | -€11,166 | -€1,097 | -10.9% |
| Financial income | 75/76B | €3,263 | €3,864 | +€601 | +18.4% |
| Recurring financial income | 75 | €3,263 | €3,864 | +€601 | +18.4% |
| Financial charges | 65/66B | €440 | €454 | +€14 | +3.3% |
| Recurring financial charges | 65 | €440 | €454 | +€14 | +3.3% |
| Profit (loss) for the period before taxes | 9903 | -€7,246 | -€7,757 | -€511 | -7.0% |
| Profit (loss) for the period | 9904 | -€7,246 | -€7,757 | -€511 | -7.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€7,246 | -€7,757 | -€511 | -7.0% |
Source: filed annual accounts (NBB), financial years ended 30 June 2025 and 30 June 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.